Tatsuoka, Yoshihisa
Takeshima, Takao
Ozeki, Akichika
Matsumura, Taka
Clinical trials referenced in this document:
Documents that mention this clinical trial
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study
https://doi.org/10.1007/S40120-021-00236-5
Funding for this research was provided by:
Eli Lilly Japan
Article History
Received: 7 December 2020
Accepted: 19 February 2021
First Online: 9 April 2021